Due to the site upgrade, your MY ACCOUNT logins will need to be updated. Please access Forgot Your Password to make this change. If you do not have an account, click here.

Europe approves important health claims for magnesium

Jul 23, 2014

efsa

The following are approved health claims in European Union member countries for the mineral Magnesium. Magnesium is required for hundreds of metabolic activities in the human body.

The European Food Safety Authority has been busily reviewing submitted data in relation to health claims for nutritional supplements. The following has been taken verbatim from their journal; EFSA Journal 2010;8(10):1807

Magnesium and the reduction of tiredness or fatigue

The claimed effect is “vitamin/mineral supplementation to reduce fatigue and tiredness in situations of inadequate micronutrient status”. The target population is assumed to be the general population. The Panel considers that reduction of tiredness and fatigue is a beneficial physiological effect.

A decline in magnesium status is associated with various symptoms such as nausea, muscular weakness, fatigue or staggering.

The Panel concludes that a cause and effect relationship has been established between the dietary intake of magnesium and a reduction of tiredness and fatigue.

Magnesium’s contribution to normal psychological functions

The claimed effects are “the role of vitamins and minerals in mental performance (where mental performance stands for those aspects of brain and nerve functions which determine aspects like concentration, learning, memory and reasoning)” and “brain function”. The target population is assumed to be the general population. The Panel considers that contribution to normal psychological functions, which encompass cognitive and affective domains, is a beneficial physiological effect.

A decline in magnesium status is associated with various symptoms such as depression, psychosis, irritability or confusion.

The Panel concludes that a cause and effect relationship has been established between the dietary intake of magnesium and contribution to normal psychological functions.

Maintenance of normal muscle contraction

The claimed effects are “fonctionnement musculaire” and “metabolism/muscle function”. The target population is assumed to be the general population.
In the context of the proposed wordings, the Panel assumes that the claimed effects refer to the maintenance of normal muscle contraction.

A claim on magnesium and muscle contraction has already been assessed with a favorable outcome.

Magnesium and its contribution to “Hormonal health”

The claimed effect is “an essential co-factor in fatty acid metabolism that impacts upon hormonal health”. The target population is assumed to be the general population.

The Panel considers that the claimed effect is general and non-specific and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.

Claims submitted for magnesium and blood pressure regulation and blood sugar control require additional research support